This is thought to be because these medications impact the brain's hypothalamus, which is basically the brain's control center because it regulates mood, hunger, thirst and body temperature
Based on what little data exists, ipamorelin does not appear to cause adverse effects when taken on a short-term basis and the few reported side effects seem similar to those caused by other GHSs like sermorelin [6]
Enhances glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and signals the hypothalamus to reduce appetite
PlexusDx begins compounded semaglutide injection at evidence-based low doses with structured increases aligned to your tolerance
This has led to increased interest in GLP-1 drugs for weight management, even among non-diabetics
It is designed for individuals with a BMI of 21 or higher and starts with an intake survey and clinician consultation